Skip to main content

Table 1 Demographics and clinical characteristics of 56 newly diagnosed AML patients in this study

From: Sp1 and c-Myc modulate drug resistance of leukemia stem cells by regulating survivin expression through the ERK-MSK MAPK signaling pathway

Characteristics (n) Survivin CD34+ expression, n (%) CD34- expression, n (%)
Sex   
Female (17) 8 (47%) 9 (53%)
Male (39) 23 (59%) 16 (41%)
P value 0.342  
Age   
≤40 years old (30) 19 (63%) 11 (37%)
>40 years old (24) 10 (42%) 14 (58%)
P value 0.226  
FAB   
M0 (5) 3 (60%) 2 (40%)
M1 (12) 10 (83%) 2 (17%)
M2 (8) 2 (25%) 6 (75%)
M5 (23) 17 (74%) 6 (26%)
M7 (8) 1 (13%) 7 (87%)
P value 0.148  
Laboratory analysis (median)   
WBC (109/L) 16.4 15.8
Platelet (109/L) 87 106
Hemoglobin (g/dL) 9.6 4.3
BM blast, % 36 21
PB blast, % 17 10
P value 0.174